Ineligibility for Anticoagulation in Patients with Atrial Fibrillation
Authors:
- Jonathan L. HalperinJHJonathan L. Halperin
- 1 February 2013
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 126 (2) , 105-111
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2011
- Identifying Patients at High Risk for Stroke Despite AnticoagulationStroke, 2010
- Newly Identified Events in the RE-LY TrialNew England Journal of Medicine, 2010
- Guidelines for the management of atrial fibrillationEP Europace, 2010
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- A Clinical Prediction Rule to Identify Patients With Atrial Fibrillation and a Low Risk for Stroke While Taking AspirinArchives of internal medicine (1960), 2003
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001